Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Open reading frame 3a protein (ORF3a) is an accessory protein encoded by the genome of severe acute respiratory syndrome-associated coronaviruses, including SARS-CoV and SARS-CoV-2. It is the largest accessory protein in these viruses and plays significant roles in virus-host interactions, although it is not essential for viral replication in vitro or in vivo. ORF3a contributes significantly to pathogenesis by enhancing virus-induced cytopathic effects, altering intracellular trafficking and modulating immune responses indirectly through effects on cell death pathways. It is a homo-tetramer with each monomer containing three transmembrane domains. The tetrameric structure creates hydrophobic cavities that may be involved in ion channel activity ("viroporin" function) and interactions with host proteins.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Open Reading Frame 3a Protein (ORF3a).